These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8182275)

  • 1. Worldwide experience with the CR326F-derived inactivated hepatitis A virus vaccine in pediatric and adult populations: an overview.
    Nalin DR; Kuter BJ; Brown L; Patterson C; Calandra GB; Werzberger A; Shouval D; Ellerbeck E; Block SL; Bishop R
    J Hepatol; 1993; 18 Suppl 2():S51-5. PubMed ID: 8182275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated hepatitis A vaccine in childhood: implications for disease control.
    Nalin D; Brown L; Kuter B; Patterson C; McGuire B; Werzberger A; Santosham M; Block S; Reisinger K; Watson B
    Vaccine; 1993; 11 Suppl 1():S15-7. PubMed ID: 8383388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety, tolerability and immunogenicity of a formalin-inactivated hepatitis A vaccine (VAQTA) in rural Kentucky children.
    Block SL; Hedrick JA; Tyler RD; Smith RA; Calandra G; Patterson C; Lewis J; Sitrin R; Miller W; Schwartz S
    Pediatr Infect Dis J; 1993 Dec; 12(12):976-80. PubMed ID: 8108223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults.
    Reuman PD; Kubilis P; Hurni W; Brown L; Nalin D
    Vaccine; 1997 Jul; 15(10):1157-61. PubMed ID: 9269062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine.
    Theilmann L; Kallinowski B; Gmelin K; Hofmann F; Scheiermann N; Wohland B; Stickl H; Maiwald H; Moriabadi FK; Bock HL
    Vaccine; 1992; 10 Suppl 1():S132-4. PubMed ID: 1335644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings.
    André FE; D'Hondt E; Delem A; Safary A
    Vaccine; 1992; 10 Suppl 1():S160-8. PubMed ID: 1335652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the formalin-inactivated hepatitis A vaccine, VAQTA from the live attenuated virus strain CR326F.
    Armstrong ME; Giesa PA; Davide JP; Redner F; Waterbury JA; Rhoad AE; Keys RD; Provost PJ; Lewis JA
    J Hepatol; 1993; 18 Suppl 2():S20-6. PubMed ID: 8182268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of immunogenicity of two hepatitis A vaccines--VAQTA and HAVRIX--in young adults.
    Ashur Y; Adler R; Rowe M; Shouval D
    Vaccine; 1999 May; 17(18):2290-6. PubMed ID: 10403597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with an inactivated hepatitis A vaccine.
    Clemens R; Safary A; Hepburn A; Roche C; Stanbury WJ; André FE
    J Infect Dis; 1995 Mar; 171 Suppl 1():S44-9. PubMed ID: 7876648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine.
    Dagan R; Greenberg D; Goldenbertg-Gehtman P; Vidor E; Briantais P; Pinsk V; Athias O; Dumas R
    Vaccine; 1999 Apr; 17(15-16):1919-25. PubMed ID: 10217590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children.
    Castillo de Febres O; Chacon de Petrola M; Casanova de Escalona L; Naveda O; Naveda M; Estopinan M; Bordones G; Zambrano B; Garcia A; Dumas R
    Vaccine; 1999 Nov; 18(7-8):656-64. PubMed ID: 10547425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children.
    Werzberger A; Mensch B; Kuter B; Brown L; Lewis J; Sitrin R; Miller W; Shouval D; Wiens B; Calandra G
    N Engl J Med; 1992 Aug; 327(7):453-7. PubMed ID: 1320740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hepatitis A vaccination schedules on immune response.
    Tilzey AJ; Palmer SJ; Barrow S; Perry KR; Tyrell H; Safary A; Banatvala JE
    Vaccine; 1992; 10 Suppl 1():S121-3. PubMed ID: 1335640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placebo-controlled efficacy study of hepatitis A vaccine in Valdivia, Chile.
    Riedemann S; Reinhardt G; Frösner GG; Ibarra H; Moraleda L; Hering V; Siegel F; Toledo C; Leon J; Gonzalez JL
    Vaccine; 1992; 10 Suppl 1():S152-5. PubMed ID: 1335650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.
    Just M; Berger R; Dreschsler H; Brantschen S; Glück R
    Vaccine; 1992; 10(11):737-9. PubMed ID: 1441728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.